RESPIVAX
LIVE

Serial Number

87721290

Owner

HUVEPHARMA, INC.

Attorney

Charles G. Zug

First Use Date

Jan 7, 2020

Filing Date

Dec 14, 2017

Add to watchlist:

No watchlists yet
View on USPTO

RESPIVAX Trademark

Serial Number: 87721290 • Registration: 6048109

RESPIVAX is a trademark filed by HUVEPHARMA, INC. on December 14, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

HUVEPHARMA, INC. (82 trademarks)

525 WESTPARK DRIVE
PEACHTREE CITY, GA 30269

Entity Type: 03

AGRI LABORATORIES, LTD. (156 trademarks)

KANSAS CITY, MO 649101350

Entity Type: 03

Trademark Details

Filing Date

December 14, 2017

Registration Date

May 5, 2020

First Use Anywhere

January 7, 2020

First Use in Commerce

January 7, 2020

Published for Opposition

May 22, 2018

Goods & Services

Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; bacteriophage antimicrobials for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; immunorestorative biopharmaceuticals for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; parasiticides; insecticides; medicinal drugs for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; dietary supplements; and hormone preparations

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 5, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 25, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 25, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 25, 2023 COAR
REGISTERED-PRINCIPAL REGISTER
May 5, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 31, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 30, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 27, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 27, 2020 AITU
USE AMENDMENT FILED
Mar 10, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 10, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2019 EXRA
SOU EXTENSION 2 GRANTED
Aug 14, 2019 EX2G
SOU EXTENSION 2 FILED
Aug 14, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 14, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2019 EXRA
SOU EXTENSION 1 GRANTED
Mar 8, 2019 EX1G
SOU EXTENSION 1 FILED
Mar 8, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 8, 2019 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 31, 2018 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 11, 2018 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 1, 2018 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 18, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 22, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 22, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 2, 2018 NONP
ASSIGNED TO LIE
Apr 16, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 2, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 2, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 2, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 2, 2018 CNEA
ASSIGNED TO EXAMINER
Mar 26, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2017 NWOS
NEW APPLICATION ENTERED
Dec 18, 2017 NWAP